跳至主要内容
临床试验/IRCT201402191141N18
IRCT201402191141N18已完成3 期

Subcutaneous progesterone (Prolutex) versus vaginal (Cyclogest) for luteal phase support in IVF/ICSI cycles: a randomized controlled clinical trial study phase 3

Royan Institute0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 years 至 39 years(—)
性别
Female

入选标准

  • Inclusion Criteria:
  • Female age 19–39 years ; An written consent to participate in the study ;Body mass index (BMI ) <30 kg/m2

排除标准

  • Severe male infertility (TESE, PESA) ; The uterine cause of infertility (uterine surgery history, cervical insufficiency, submucosal myoma or intramural fibroids = 5 cm and multiple uterine polyps) ; Patients with poor ovarian response or patients with reduced ovarian reserve (FSH = 15 IU/ml, AMH = 1 ng/ml) ; Tubal factor was diagnosed as hydrosalpinx ; Moderate and severe endometriosis (stage3and 4) ; Cases of repeated implantation failure (RIF) and spontaneous abortions.

研究者

相似试验